The Vetoquinol Group announced sales results for the fourth quarter and full year of 2015. The company posted 2015 sales of €342.6 million, up 8.7% on reported data and up 3.8% at constant exchange rates. The group benefited from a positive currency impact of 4.9% mainly linked to the US dollar, Indian rupee and British pound.

Fourth quarter 2015 sales were strong, up 8.5% to €90.8 million (6.2% organic growth), partly driven by the recent European launches of Upcard® and Permacyl®.